Three clinical performance studies were conducted to produce newborn CK-MM distribution data in the Danish and US population using the GSP CK-MM assay and evaluate the assay’s ability to distinguish newborns at an increased risk for DMD from the normal population. The gene discussed is CKM; the disease is Duchenne muscular dystrophy.